Ignite Creation Date:
2025-12-24 @ 12:21 PM
Ignite Modification Date:
2026-01-06 @ 6:35 PM
Study NCT ID:
NCT00118261
Status:
COMPLETED
Last Update Posted:
2012-09-03
First Post:
2005-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer
Sponsor:
Organization: